Tuesday, 02 January 2024 12:17 GMT

Healthcare Specialty Enzymes Forecast Report 2025: A $7.94 Billion Market By 2030, Driven By Rising Chronic And Infectious Diseases And Expanding Diagnostic And Therapeutic Applications


(MENAFN- GlobeNewsWire - Nasdaq) The Global Healthcare Specialty Enzymes Market is driven by the rising prevalence of chronic diseases and demand for advanced diagnostics. Key opportunities lie in enzyme engineering for enhanced performance and therapeutic solutions, despite challenges from high R&D costs and regulatory hurdles.

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Healthcare Specialty Enzymes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets's offering.
The Global Healthcare Specialty Enzymes Market, valued at USD 5.32 Billion in 2024, is projected to experience a CAGR of 6.91% to reach USD 7.94 Billion by 2030.

Healthcare specialty enzymes are highly specific biocatalysts crucial for accelerating biochemical reactions in numerous medical applications, including diagnostics, therapeutics, drug development, and biotechnological research. The market's growth is primarily driven by the increasing prevalence of chronic diseases, such as cardiovascular conditions and cancer, which necessitate advanced diagnostic and therapeutic solutions.

Key Market Drivers
The rising prevalence of chronic and infectious diseases significantly propels the Global Healthcare Specialty Enzymes Market by increasing the necessity for advanced diagnostic tools and therapeutic interventions. Enzymes are fundamental in the accurate detection and effective management of a broad spectrum of conditions, from metabolic disorders to infectious outbreaks. For instance, diagnostic enzymes are crucial in biomarker detection for early disease identification, while therapeutic enzymes offer targeted approaches for disease treatment, particularly in areas like oncology and genetic disorders.
Key Market Challenges
High research and development costs associated with novel enzyme discovery and optimization, coupled with stringent regulatory approval processes for therapeutic enzymes, present substantial impediments to the expansion of the Global Healthcare Specialty Enzymes Market. These financial burdens limit the ability of companies, particularly smaller entities, to invest in innovative enzyme engineering and bioprocessing research. The extended timelines and significant capital required for preclinical and clinical development, alongside high attrition rates, diminish investment appeal and delay market entry for promising new enzyme applications.
Key Market Trends
Advancements in enzyme engineering for enhanced performance represent a critical driver for the Global Healthcare Specialty Enzymes Market, fostering the development of enzymes with superior catalytic activity, stability, and specificity required for complex medical applications. This trend involves optimizing enzyme structures and functions through various biotechnological methods, leading to more robust and efficient biocatalysts. According to AseBio, in its 2024 report, the biotech sector in Spain invested 1.28 billion euros in research and development during 2023, marking a 5.2% increase over the previous year, demonstrating sustained investment in core biotechnological innovation. This focus on engineering extends to creating enzymes capable of withstanding harsh physiological conditions or demanding manufacturing processes.

Key Attributes:

Report Attribute Details
No. of Pages 185
Forecast Period 2024 - 2030
Estimated Market Value (USD) in 2024 $5.32 Billion
Forecasted Market Value (USD) by 2030 $7.94 Billion
Compound Annual Growth Rate 6.9%
Regions Covered Global

Report Scope:
Key Market Players Profiled:

  • Merck KgaA
  • Advanced Enzyme Technologies Ltd
  • Amano Enzymes, Inc.
  • Amicogen Co., Ltd.
  • BBI Solutions OEM Limited
  • Biotechrabbit GmbH
  • Brain Biotech AG
  • Cpc Biotech S.R.L.
  • EKF Diagnostics Holdings PLC

By Product:

  • Carbohydrase
  • Polymerase and Nuclease
  • Protease
  • Lipases
  • Phosphates
  • Others

By Source:

  • Microbial
  • Plants
  • Animals

By Application:

  • Infectious diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Healthcare Specialty Enzymes Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN01122025004107003653ID1110419853



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search